Table 3 Association parameters of rules based on the number of administered drugs and the stratified age group (sort by lift)

[1]

{4 CNS-active drugs, 70–79 years}

=>

{fall-related events}

[2]

{1 calcium channel blocker, 4 CNS-active drugs}

=>

{fall-related events}

[3]

{2 calcium channel blockers, 90–99 years}

=>

{fall-related events}

[4]

{3 CNS-active drugs, 70–79 years}

=>

{fall-related events}

[5]

{4 CNS-active drugs, 60–69 years}

=>

{fall-related events}

[6]

{2 CNS-active drugs, 80–89 years}

=>

{fall-related events}

[7]

{3 CNS-active drugs, 80–89 years}

=>

{fall-related events}

[8]

{1 CNS-active drug, 80–89 years}

=>

{fall-related events}

[9]

{5 CNS-active drugs}

=>

{fall-related events}

[10]

{10–19 years}

=>

{fall-related events}

[11]

{2 CNS-active drugs, 70–79 years}

=>

{fall-related events}

[12]

{1 CNS-active drug, 10–19 years}

=>

{fall-related events}

[13]

{1 CNS-active drug, 2 calcium channel blockers}

=>

{fall-related events}

[14]

{4 CNS-active drugs}

=>

{fall-related events}

[15]

{1 CNS-active drug, 90–99 years}

=>

{fall-related events}

[16]

{10–19 years, 2 CNS-active drugs}

=>

{fall-related events}

[17]

{1 calcium channel blocker, 80–89 years}

=>

{fall-related events}

[18]

{1 CNS-active drug, 20–29 years}

=>

{fall-related events}

[19]

{2 calcium channel blockers, 50–59 years}

=>

{fall-related events}

[20]

{2 calcium channel blockers, 70–79 years}

=>

{fall-related events}

[21]

{3 CNS-active drugs}

=>

{fall-related events}

[22]

{2 CNS-active drugs}

=>

{fall-related events}

[23]

{1 calcium channel blocker, 3 CNS-active drugs}

=>

{fall-related events}

[24]

{1 CNS-active drug}

=>

{fall-related events}

[25]

{3 CNS-active drugs, 30–39 years}

=>

{fall-related events}

[26]

{80–89 years}

=>

{fall-related events}

[27]

{3 CNS-active drugs, 60–69 years}

=>

{fall-related events}

[28]

{1 CNS-active drug, 70–79 years}

=>

{fall-related events}

[29]

{1 CNS-active drug, 1 calcium channel blocker}

=>

{fall-related events}

[30]

{2 CNS-active drugs, 60–69 years}

=>

{fall-related events}

[31]

{90–99 years}

=>

{fall-related events}

[32]

{1 calcium channel blocker, 90–99 years}

=>

{fall-related events}

[33]

{1 CNS-active drug, 40–49 years}

=>

{fall-related events}

[34]

{2 CNS-active drugs, 30–39 years}

=>

{fall-related events}

[35]

{1 calcium channel blocker, 70–79 years}

=>

{fall-related events}

[36]

{1 CNS-active drug, 50–59 years}

=>

{fall-related events}

[37]

{2 calcium channel blockers}

=>

{fall-related events}

[38]

{1 calcium channel blocker, 2 CNS-active drugs}

=>

{fall-related events}

[39]

{1 calcium channel blocker}

=>

{fall-related events}

[40]

{3 CNS-active drugs, 40–49 years}

=>

{fall-related events}

[41]

{2 CNS-active drugs, 40–49 years}

=>

{fall-related events}

[42]

{70–79 years}

=>

{fall-related events}

[43]

{1 CNS-active drug, 60–69 years}

=>

{fall-related events}

[44]

{1 calcium channel blocker, 60–69 years}

=>

{fall-related events}

[45]

{2 CNS-active drugs, 20–29 years}

=>

{fall-related events}

[46]

{1CNS-active drug, 30–39 years}

=>

{fall-related events}

[47]

{3 CNS-active drugs, 50–59 years}

=>

{fall-related events}

[48]

{2 CNS-active drugs, 50–59 years}

=>

{fall-related events}

[49]

{1 calcium channel blocker, 40–49 years}

=>

{fall-related events}

[50]

{2 calcium channel blockers, 80–89 years}

=>

{fall-related events}

[51]

{60–69 years}

=>

{fall-related events}

[52]

{20–29 years}

=>

{fall-related events}

[53]

{40–49 years}

=>

{fall-related events}

[54]

{50–59 years}

=>

{fall-related events}

[55]

{2 calcium channel blockers, 60–69 years}

=>

{fall-related events}

[56]

{30–39 years}

=>

{fall-related events}

[57]

{1 calcium channel blocker, 50–59 years}

=>

{fall-related events}

[58]

{1 calcium channel blocker, 30–39 years}

=>

{fall-related events}